Bih-Rong Wei

Title: Bih-Rong Wei: Innovator in Renal Cell Carcinoma Biomarkers

Introduction

Bih-Rong Wei is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of medical research, particularly in the identification of biomarkers for renal cell carcinoma. With a total of 2 patents, his work is paving the way for advancements in cancer diagnostics and treatment.

Latest Patents

Wei's latest patents focus on methods for identifying tumor biomarkers associated with renal cell carcinoma (RCC). One of the key innovations involves obtaining a peripheral biological fluid sample from a subject with a tumor, alongside tumor and adjacent non-tumor samples. By detecting and comparing protein expression profiles in these samples, Wei's methods can identify specific proteins that serve as biomarkers for tumors. Additionally, his patents disclose a gene profiling signature that aids in diagnosing RCC and identifying therapeutic agents for treatment.

Career Highlights

Bih-Rong Wei is affiliated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been instrumental in advancing the understanding of renal cell carcinoma and improving diagnostic methods.

Collaborations

Wei has collaborated with esteemed colleagues such as Josip Blonder and Donald J Johann, Jr. These partnerships have further enhanced the impact of his research in the medical community.

Conclusion

Bih-Rong Wei's innovative work in identifying renal cell carcinoma biomarkers is a testament to his dedication to improving cancer diagnostics and treatment. His contributions are vital in the ongoing fight against cancer, and his patents reflect a commitment to advancing medical science.